Example: barber
Stability Testing of Pharmaceutical Products in a Global ...
Regulatory Feature The stability of finished pharmaceutical products depends on environmental and product-related factors ICH and WHO started discussions in 2000 to
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Annex 2 Stability testing of active pharmaceutical ...
apps.who.int89 2. Guidelines 2.1 Active pharmaceutical ingredient 2.1.1 General Information on the stability of the API is an integral part of the systematic approach to stability evaluation. Potential attributes to be …
STABILITY TESTING OF ACTIVE PHARMACEUTICAL ... - …
www.who.intWorking document QAS/17.694 page 5 102 Stability testing of active pharmaceutical ingredients and 103 finished pharmaceutical products 104 1. Introduction 1.1 Objectives of these guidelines105 106 1.2 Scope of these guidelines 107 1.3 General principles 108 2. Guidelines 109 2.1 Active pharmaceutical ingredient 2.1.1 General110 2.1.2 Stress testing111 112 2.1.3 Selection of batches
ISSN: 2231 Stability Testing of Pharmaceutical Products
japsonline.comJournal of Applied Pharmaceutical Science 02 (03); 2012: 129-138 ISSN: 2231 followed for stability testing of pharmaceutical products, guidelines issued for stability testing
Registration of Medicines Stability - ICH Official web site
www.ich.orgRegistration of Medicines Stability Stability v1.doc March 2004 1 SADC GUIDELINE FOR STABILITY TESTING 2004 This guideline is intended to provide requirements to applicants wishing to submit
Strategies for In Vitro Metabolic Stability Testing ...
www.bdbiosciences.comStrategies for In Vitro Metabolic Stability Testing Christopher Patten, PhD BD Biosciences December 2, 2009
Guideline on stability testing for applications for ...
www.ema.europa.eu1. Introduction (background) This guideline describes the stability testing requirements for variations to a marketing a uthorisation after approval.
Stability Existing Corrected March 2007 - ema.europa.eu
www.ema.europa.euCPMP/QWP/122/02, rev 1 corr EMEA 2007 3/18 STABILITY TESTING OF EXISTING ACTIVE SUBSTANCES AND RELATED FINISHED PRODUCTS 1. INTRODUCTION 1.1 …